Skip to main content
Log in

Minimal Extrathyroidal Extension in Patients with Papillary Thyroid Microcarcinoma: Is It a Real Prognostic Factor?

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The clinical impact of minimal extrathyroidal extension (ETE) in patients with conventional papillary thyroid microcarcinoma (PTMC) is still controversial. The clinicopathologic characteristics of patients with or without minimal ETE or recurrence and the clinical impact of minimal ETE were investigated.

Methods

This study included 288 patients with conventional PTMC (mean age, 46.6 years; 262 female and 26 male subjects) and more than 5 years of follow-up. Patients were divided into two groups according to ETE and recurrence, and clinicopathologic characteristics between two groups were investigated. Disease-free survival was calculated to compare the clinical impact of minimal ETE between patients with and without ETE.

Results

Mean size (6.9 mm) of PTMCs in patients with minimal ETE (n = 89) was significantly larger than that in those (5.8 mm) without (n = 199) (P < 0.001). Tumor size [odds ratio (OR) = 1.185; 95% confidence interval (CI) 1.052–1.334], central lymph node (LN) metastasis at diagnosis (OR 2.105; 95% CI 1.182–3.750), and not well-defined margin on ultrasound (OR 3.808; 95% CI 1.055–13.736) were significantly associated with minimal ETE. Twelve patients (4.2%) had recurrence. No clinicopathologic factor was associated with recurrence. Disease-free survival was not significantly different between patients with and without minimal ETE (P = 0.671).

Conclusions

Minimal ETE was statistically significantly associated with tumor size, central LN metastasis, and not well-defined margin on ultrasound. Minimal ETE had no impact on recurrence in patients with conventional PTMC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–7.

    Article  PubMed  CAS  Google Scholar 

  2. Lee J, Rhee Y, Lee S, et al. Frequent, aggressive behaviors of thyroid microcarcinomas in Korean patients. Endocr J. 2006;53:627–32.

    Article  PubMed  Google Scholar 

  3. Mazzaferri EL. Managing small thyroid cancers. JAMA. 2006;295:2179–82.

    Article  PubMed  CAS  Google Scholar 

  4. DeLellis RA, Lloyd RV, Heitz PU, Eng C. WHO classification of tumors. Pathology and genetics. Lyon: IARC Press; 2004.

    Google Scholar 

  5. Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28–35.

    Article  PubMed  Google Scholar 

  6. Cappelli C, Castellano M, Braga M, et al. Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol. 2007;95:555–60.

    Article  PubMed  CAS  Google Scholar 

  7. Chow S, Law SC, Chan JK, Au S, Yau S, Lau W. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31–40.

    Article  PubMed  Google Scholar 

  8. Lin KD, Lin JD, Huang HS, Jeng LB, Ho YS. Skull metastasis with brain invasion from thyroid papillary microcarcinoma. J Formos Med Assoc. 1997;96:280–2.

    PubMed  CAS  Google Scholar 

  9. Liou M, Lin J, Chung M, Liau C, Hsueh C. Renal metastasis from papillary thyroid microcarcinoma. Acta Otolaryngol. 2005;125:438–42.

    Article  PubMed  CAS  Google Scholar 

  10. Arora N, Turbendian HK, Kato MA, Moo TA, Zarnegar R, Fahey TJ. Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid. 2009;19:473–7.

    Article  PubMed  Google Scholar 

  11. Edge SB, Compton CC, Byrd DR. AJCC cancer staging manual, 7th edition. New York: Springer; 2010.

    Google Scholar 

  12. Andersen PE, Kinsella J, Loree TR, Shaha AR, Shah JP. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg. 1995;170:467–70.

    Article  PubMed  CAS  Google Scholar 

  13. Brierley JD, Panzarella T, Tsang RW, Gospodarowicz MK, O’Sullivan B. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example. Cancer. 1997;79:2414–23.

    Article  PubMed  CAS  Google Scholar 

  14. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma. A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer. 1979;15:1033–41.

    PubMed  CAS  Google Scholar 

  15. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104:947–53.

    PubMed  CAS  Google Scholar 

  16. DeGroot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71:414–24.

    Article  PubMed  CAS  Google Scholar 

  17. Greenle FL, Page DL, Fleming ID. AJCC cancer staging manual, 6th edition. New York: Springer; 2002.

    Book  Google Scholar 

  18. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050–7.

    PubMed  CAS  Google Scholar 

  19. Hay ID, Grant CS, Taylor WF, McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102:1088–95.

    PubMed  CAS  Google Scholar 

  20. Ito Y, Tomoda C, Uruno T, et al. Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today. 2006;36:12–8.

    Article  PubMed  Google Scholar 

  21. Ito Y, Tomoda C, Uruno T, et al. Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg. 2006;30:780–6.

    Article  PubMed  Google Scholar 

  22. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case–control study. Cancer. 2006;106:524–31.

    Article  PubMed  Google Scholar 

  23. Ortiz S, Rodrguez JM, Soria T, et al. Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study. Otolaryngol Head Neck Surg. 2001;124:261–5.

    Article  PubMed  CAS  Google Scholar 

  24. Palme CE, Waseem Z, Raza SN, Eski S, Walfish P, Freeman JL. Management and outcome of recurrent well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:819–24.

    Article  PubMed  Google Scholar 

  25. Wada N, Nakayama H, Suganuma N, et al. Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension. J Clin Endocrinol Metab. 2007;92:215–8.

    Article  PubMed  CAS  Google Scholar 

  26. Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab. 1997;82:3553–62.

    Article  PubMed  CAS  Google Scholar 

  27. Bisi H, Fernandes VS, de Camargo RY, Koch L, Abdo AH, de Brito T. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer. 1989;64:1888–93.

    Article  PubMed  CAS  Google Scholar 

  28. Bramley MD, Harrison BJ. Papillary microcarcinoma of the thyroid gland. Br J Surg. 1996;83:1674–83.

    Article  PubMed  CAS  Google Scholar 

  29. Franssila KO, Harach HR. Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer. 1986;58:715–9.

    Article  PubMed  CAS  Google Scholar 

  30. Noguchi S, Yamashita H, Uchino S, Watanabe S. Papillary microcarcinoma. World J Surg. 2008;32:747–53.

    Article  PubMed  Google Scholar 

  31. Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer. 1990;65:1173–9.

    Article  PubMed  CAS  Google Scholar 

  32. Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144:980–7.

    Article  PubMed  Google Scholar 

  33. Kwak JY, Kim E, Chung WY, Moon HJ, Kim MJ, Choi JR. Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma. Radiology. 2009;253:854–60.

    Article  PubMed  Google Scholar 

  34. Mercante G, Frasoldati A, Pedroni C, et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009;19:707–16.

    Article  PubMed  CAS  Google Scholar 

  35. Kwak JY, Kim E, Youk JH, et al. Extrathyroid extension of well-differentiated papillary thyroid microcarcinoma on US. Thyroid. 2008;18:609–14.

    Article  PubMed  Google Scholar 

  36. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.

    Article  PubMed  Google Scholar 

  37. Lee YS, Nam K, Chung WY, Chang H, Park CS. Postoperative complications of thyroid cancer in a single center experience. J Korean Med Sci. 2010;25:541–5.

    Article  PubMed  Google Scholar 

  38. Besic N, Pilko G, Petric R, Hocevar M, Zgajnar J. Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol. 2008;97:221–5.

    Article  PubMed  Google Scholar 

  39. Lim D, Baek K, Lee Y, et al. Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid. 2007;17:883–8.

    Article  PubMed  CAS  Google Scholar 

  40. Lombardi CP, Bellantone R, De Crea C, et al. Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg. 2010;34:1214–21.

    Article  PubMed  Google Scholar 

  41. Sobin LH, Wittekind Ch, Greene FL, Hutter R, Klimpfinger M. TNM classification of malignant tumors, 5th edition. New York: Wiley; 1997.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jin Young Kwak MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moon, H.J., Kim, EK., Chung, W.Y. et al. Minimal Extrathyroidal Extension in Patients with Papillary Thyroid Microcarcinoma: Is It a Real Prognostic Factor?. Ann Surg Oncol 18, 1916–1923 (2011). https://doi.org/10.1245/s10434-011-1556-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-011-1556-z

Keywords

Navigation